Interact to see
Advertisement
Advertisement
HROAX vs JEPCX
HROAX vs JEPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HROAX vs. JEPCX commentary
Jul 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROAX is a Buy and JEPCX is a Buy.
FUNDAMENTALS
Fundamentals
JEPCX has more cash in the bank: 6.43B vs. HROAX (35M). JEPCX pays higher dividends than HROAX: JEPCX (7.52) vs HROAX (0.00). HROAX was incepted earlier than JEPCX: HROAX (9 years) vs JEPCX (7 years). HROAX (3.01) is less costly to investors than JEPCX (1.35). HROAX is a more actively managed with annual turnover of: 487.35 vs. JEPCX (176.00). HROAX (1000) and JEPCX (1000) have matching initial minimum investment requirements. HROAX annual gain was more profitable for investors over the last year : 10.94 vs. JEPCX (9.00). JEPCX return over 5 years is better than : 65.03 vs. HROAX (26.04).
| HROAX | JEPCX | HROAX / JEPCX | |
| Total Expense Ratio | 2.46 | 1.35 | 182% |
| Annual Report Gross Expense Ratio | 3.01 | 1.35 | 223% |
| Fund Existence | 9 years | 7 years | - |
| Gain YTD | 6.376 | 2.831 | 225% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 35M | 6.43B | 1% |
| Annual Yield % from dividends | 0.00 | 7.52 | - |
| Returns for 1 year | 10.94 | 9.00 | 121% |
| Returns for 3 years | 38.58 | 29.60 | 130% |
| Returns for 5 years | 26.04 | 65.03 | 40% |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SWLGX | 127.20 | 1.43 | +1.14% |
| Schwab ® US Large-Cap Growth Idx | |||
| RYVFX | 9.96 | 0.08 | +0.81% |
| Royce Small-Cap Value Service | |||
| RNWFX | 90.05 | 0.56 | +0.63% |
| American Funds New World R5 | |||
| FQTEX | 13.36 | 0.04 | +0.30% |
| Franklin Templeton SMACS: Series E Adv | |||
| CSHCX | 8.72 | N/A | N/A |
| NYLI Cushing® MLP Premier Class C | |||